Skip to content

Clinical Trial of Amrutadi Syrup in Urticaria

An Open Labelled Randomized Controlled trial to evaluate the efficacy of â??Amrutadi Kashayaâ?? in the management of Sheetpitta with special reference to Urticaria - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078684
Enrollment
54
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Sponsors

Dr Krutika Ramesh Jangale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 The age limit is from 18 to 70 years.13 2 Patient suffering from Cardinals signs Mandalotpatti,Kandu and Associated symptoms of Sheetpitta (Urticaria) Daha,Toda,Jwar,Chhardi. 3 Patients with reocurrence within 6 months will be included. 4 Patients will be selected irrespective of Sex & Socioeconomic status.

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women. 2 Patients with severe vomiting, diarrhoea and those who cannot take medicine orally. 3 Sheetpitta along with other chronic diseases and their associated complications. 4 Patient having major medical or surgical Illness. 5 Patients with a history of systemic illness like Diabetes mellitus, Hypertension, Endocrine disorder, Cardiac pathology, and Immunodeficiency disorders like AIDS. 6 Patient with drug-induced Sheetpitta (Urticaria).

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Amrutadi Kashaya in the management of SheetpittaTimepoint: 15 DAYS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Krutika Ramesh Jangale

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

krutikajangalekruz@gmail.com09168722181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026